Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

2.

Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation.

Kornberg A, Schotte U, Kupper B, Hommann M, Scheele J.

Hepatogastroenterology. 2004 Mar-Apr;51(56):526-31.

PMID:
15086195
3.

Procalcitonin in liver transplantation: are high levels due to donors or recipients?

Eyraud D, Ben Ayed S, Tanguy ML, Vézinet C, Siksik JM, Bernard M, Fratéa S, Movschin M, Vaillant JC, Coriat P, Hannoun L.

Crit Care. 2008;12(4):R85. doi: 10.1186/cc6942. Epub 2008 Jul 4.

4.

Perioperative prostaglandin e1 infusion in living donor liver transplantation: A double-blind, placebo-controlled randomized trial.

Bharathan VK, Chandran B, Gopalakrishnan U, Varghese CT, Menon RN, Balakrishnan D, Sudheer OV, Dhar P, Surendran S.

Liver Transpl. 2016 Aug;22(8):1067-74. doi: 10.1002/lt.24479.

5.

Analysis of systemic and regional procalcitonin serum levels during liver transplantation.

Fazakas J, Gondos T, Varga M, Sarvary E, Horovitz P, Perner F.

Transpl Int. 2003 Jul;16(7):465-70. Epub 2003 May 1.

6.

High levels of procalcitonin in the early phase after pediatric liver transplantation indicate poor postoperative outcome.

Zant R, Melter M, Schlitt HJ, Loss M, Ameres M, Knoppke B, Kunkel J.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1344-9.

PMID:
25436308
7.

Prostaglandins in liver transplantation.

Merion RM.

Adv Exp Med Biol. 1997;433:13-8. Review.

PMID:
9561096
8.

Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation.

Kawachi S, Shimazu M, Wakabayashi G, Tanabe M, Shirasugi N, Kumamoto Y, Karahashi T, Yoshida M, Kitajima M.

Transplantation. 1997 Jul 27;64(2):205-9.

PMID:
9256174
9.

Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation.

Potapov EV, Wagner FD, Loebe M, Ivanitskaia EA, Müller C, Sodian R, Jonitz B, Hetzer R.

Int J Cardiol. 2003 Dec;92(2-3):163-7.

PMID:
14659848
10.

Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?

Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R.

Clin Transplant. 1998 Jun;12(3):206-11.

PMID:
9642511
11.

Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study.

Bucuvalas JC, Ryckman FC, Krug S, Alonso MH, Balistreri WF, Kotagal U.

Pediatr Transplant. 2001 Aug;5(4):274-8.

PMID:
11472606
12.

Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation.

Mollison LC, Angus PW, Jones RM.

Med J Aust. 1991 Jul 1;155(1):51-3.

PMID:
2067441
13.

Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.

Manasia AR, Leibowitz AB, Miller CM, Silverstein JH, Schwartz M, Delgiudice R, Vallabhajosula S, Oropello JM, Benjamin E.

J Am Coll Surg. 1996 Apr;182(4):347-52.

PMID:
8605558
14.

Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.

Iberer F, Wasler A, Tscheliessnigg K, Petutschnigg B, Auer T, Müller H, Rödl S.

J Heart Lung Transplant. 1993 Mar-Apr;12(2):173-8.

PMID:
8476887
15.

A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation.

Henley KS, Lucey MR, Normolle DP, Merion RM, McLaren ID, Crider BA, Mackie DS, Shieck VL, Nostrant TT, Brown KA, et al.

Hepatology. 1995 Feb;21(2):366-72.

16.
17.

Continuous infusion of prostaglandin E1 via the superior mesenteric artery can prevent hepatic injury in hepatic artery interruption through passive portal oxygenation.

Sato T, Kato T, Kurokawa T, Yasui O, Hiroshi N, Miyazawa H, Asanuma Y, Koyama K.

Liver. 2000 Apr;20(2):179-83.

PMID:
10847488
18.

Treatment of primary liver graft nonfunction with prostaglandin E1.

Greig PD, Woolf GM, Sinclair SB, Abecassis M, Strasberg SM, Taylor BR, Blendis LM, Superina RA, Glynn MF, Langer B, et al.

Transplantation. 1989 Sep;48(3):447-53.

PMID:
2675405
19.

Doppler Parameters of the Hepatic Artery as Predictors of Graft Status in Pediatric Liver Transplantation.

Ahmad T, Chavhan GB, Avitzur Y, Moineddin R, Oudjhane K.

AJR Am J Roentgenol. 2017 Sep;209(3):671-675. doi: 10.2214/AJR.17.17902. Epub 2017 Jun 28.

PMID:
28657844
20.

Effectiveness of intraportal prostaglandin E1 administration after liver transplantation.

Shin M, Song SH, Kim JM, Kim SJ, Joh JW, Lee SK, Kwon CH.

Transplant Proc. 2012 Mar;44(2):500-4. doi: 10.1016/j.transproceed.2012.01.070.

PMID:
22410055

Supplemental Content

Support Center